Search results for

Jiayan Xie of Deqi Intellectual Property Law Corporation assesses the circumstances in which trademark coexistence agreements are effective in China, looking at the requirements for such agreements and various judgments

It is uncontroversial to say that, in years gone by, the reputation of China in the realm of IP protection and enforcement was far from good. Rightly or wrongly, the themes that were commonly associated with China included trademark squatting and counterfeiting. Concerns about IP practices even sparked the recent trade dispute between the US and China, and US authorities have been clamping down on alleged trade secrets theft by Chinese nationals.

Qian Hao and Hua Tan of Liu Shen analyse administrative enforcement of patents, highlighting improvements to the system, as well as flaws

Guanbin Xie and Bin Zhang of Lifang assess the effectiveness of copyright law in the protection of big data before moving on to detail the advantages of using competition law to protect this data

Nell Greenhouse of Kangxin evaluates different ways to enforce IP rights in China, including administrative actions, mediation, cease and desist letters and customs recordal

Mengmeng Yu and Xia Zheng of AFD China evaluate the approach of the TMO, TRAB, CNIPA and courts to malicious trademark registrations

Recently, the Shanghai Intellectual Property Court (SIPC) rendered a so-called partial or interlocutory judgment during a patent infringement lawsuit filed by the French automotive parts manufacturer Valeo against three Chinese defendants including Xiamen Lucas Automotive Parts, Xiamen Fuke Automotive Parts and an individual, Mr Chen. In this case, Valeo alleged that the wipers for cars being manufactured and sold by the defendants infringed its Chinese invention patent named "Connectors for wiper of motor vehicles and corresponding connecting devices" and, on that basis, the company requested RMB 6 million ($894,000) in damages. After careful investigation with support of technical experts, the SIPC found that the defendants' products fell into the scope of claims 1-3 and 6-10 of Valeo's patent in question and that they should immediately stop the infringement first, while the damages can be determined later.

Since the first marketing authorisation for a monoclonal antibody (Mab) in the 1980s, the patent system has never stopped adding the fuel of interest to the fire of Mabs ingenuity.

The US Federal Circuit has imposed restrictions on who can appeal against an inter partes review decision, making life difficult for some petitioners. However, there are some practical tips to consider, as Rose Cordero Prey and Eric Ding of Greenberg Traurig explain

Despite agreeing to leave the EU, the UK has implemented some important EU-wide trademark reforms into its national system. Kate Swaine and Elwin Morgan of Gowling WLG give a rundown of what will change in practice